Best peptides for immune support
Peptides researched for immune modulation, thymic function, and immune system aging.
Immune-modulating peptides work through several mechanisms — directly stimulating innate immune responses, restoring thymic T-cell output that declines with age, or modulating the inflammatory environment. Evidence quality ranges from well-studied approved drugs to preliminary Khavinson bioregulator research.
An immune-modulating peptide naturally produced by the thymus gland. Approved in over 30 countries (as Zadaxin) for hepatitis B and C treatment, though not FDA-approved in the US. One of the more clinically substantiated peptides in the wellness space.
What evidence supports
- ✓approved in 30+ countries for hepatitis B and as an immune adjuvant
- ✓clinical trials show improved immune response in immunocompromised patients
- ✓studied as adjunct therapy in certain cancers to improve immune surveillance
Key concern: not FDA-approved in the United States
A naturally occurring antimicrobial peptide produced by the human immune system. Part of the cathelicidin family, LL-37 plays a role in innate immune defense against bacteria, viruses, and fungi. Being explored for immune support and wound healing.
What evidence supports
- ✓broad-spectrum antimicrobial activity against gram-positive and gram-negative bacteria in vitro
- ✓disrupts bacterial biofilms in laboratory settings
- ✓promotes wound healing via angiogenesis and keratinocyte migration in cell studies
Key concern: no FDA-approved therapeutic applications
A polypeptide complex isolated from bovine thymus gland, developed by the Khavinson group as a bioregulator for immune function. One of the most clinically-studied Khavinson bioregulators, used in Russia for immune support in elderly and cancer patients. Often paired with Epithalon in longevity protocols.
What evidence supports
- ✓longitudinal study (Khavinson, 2003): elderly patients treated with Thymalin + Epithalon over 6–8 years showed reduced all-cause mortality vs untreated age-matched controls
- ✓clinical reports of improved T-cell counts in elderly patients with repeat dosing
- ✓reduces incidence of respiratory infections in elderly institutional patients per Russian clinical data
Key concern: longevity study lacked rigorous placebo controls and randomization by modern RCT standards
The simplest of the Khavinson bioregulators: a synthetic dipeptide of lysine and glutamic acid (Lys-Glu). Originally derived from the thymus, Vilon is proposed to modulate immune function, reduce inflammation, and slow biological aging. Its small size gives it potentially higher oral bioavailability than larger bioregulator peptides — though this is theoretical.
What evidence supports
- ✓extends lifespan in Drosophila and mice in Russian animal studies
- ✓Russian clinical data: reduced all-cause mortality in elderly populations with combined Vilon + Epithalon regimens
- ✓cell culture studies: KE peptide can modulate gene expression in immune and epithelial cell lines
Key concern: evidence exclusively from Khavinson research group — no independent replication
A tripeptide fragment derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). Gaining popularity in the biohacking community for gut health and anti-inflammatory applications, though human clinical evidence is extremely limited.
What evidence supports
- ✓demonstrated anti-inflammatory effects via NF-kB inhibition in cell studies
- ✓reduced colitis severity in multiple animal models
- ✓shown antimicrobial activity against Candida albicans and Staphylococcus aureus in vitro
Key concern: no published human clinical trials for any indication
Not sure which is right for you?
Take our quiz for a personalized recommendation based on your goals and preferences.
Take the Peptide QuizMedical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.